BN Business News
Add your company to Business Communicator →

Business · 19/11/20261 min read

Innogen Pharmaceuticals Enters into Licensing Agreement with Arcera Life Sciences for Efsubaglutide Alfa, Accelerating International Expansion

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Under the agreement, Arcera will obtain exclusive rights to Efsubaglutide Alfa in selected countries in Africa, Latin America, the Middle East and Eastern Europe, while Innogen retains the relevant rights in the rest of the world. Under the agreement, Innogen will receive US$38 million in...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →